“Repatriated” Funds Should Not Be Used For Rx Liability Costs – Congressman
This article was originally published in The Pink Sheet Daily
Executive Summary
House Ways & Means Health Subcommittee Ranking Member Stark (D-Calif.) urges the Treasury Department to prevent pharma companies such as Merck and Wyeth from using repatriated cash to cover legal expenses.